高IgE综合征诊疗进展

[1] Davis SD，Schaller J，Wedgwood RJ. Job's syndrome. Recurrent，"cold"，staphylococcal abscesses [J]. Lancet，1966，1(7445)：1013-1015.
[2] Minegishi Y，Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome：lessons from aprimary immunodeficiency [J]. Int Immunol，2009，21(2)：105-112.
[3] Esposito L，Poletti L，?Maspero C，et al. Hyper-IgE syndrome：dental implications [J]. Oral Surg Oral Med Oral Pathol Oral Radiol，2012，114(2)：147-153.
[4] Woellner C，Gertz EM，Schaffer AA，et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome [J]. J Allergy Clin Immunol，2010，125(2)：424-432.
[5] 殷凯生. 高IgE综合征的研究进展 [J]. 实用临床医药杂志, 2004，8(2)：21-24.
[6] Minegishi Y，Saito M，Tsuchiya S，et al. Dominant-negative mutations in the DNA-binding domainof STAT3 cause hyper-IgE syndrome [J]. Nature, 2007，448(7157)：1058-1062.
[7] Holland SM，DeLeo FR，Elloumi HZ，et al. STAT3 mutations in the hyper-IgE syndrome [J]. N Engl J Med，2007，357(16)：1608-1619.
[8] Zhang Q，Davis JC，Lamborn IT，et al. Combined immunodeficiency associated with DOCK8 mutations [J]. N Engl J Med，2009，361(21)：2046-2055.
[9] Engelhardt KR，McGhee S，Winkler S，et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome [J]. J Allergy Clin Immunol，2009，124(6)：1289-1302.
[10] Minegishi Y，Saito M，Morio T，et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity [J]. Immunity，2006，25(5)：745-755.
[11] Minegishi Y，Saito M，Nagasawa M，et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome [J]. J Exp Med，2009，206(6)：1291-1301.
[12] Renner ED，Rylaarsdam S，Anover-Sombke S，et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations，reduced T(H)17 cell numbers，and variably defective STAT3 phosphorylation in hyper-IgE syndrome [J]. J Allergy Clin Immunol，2008，122(1)：181-187.
[13] Mintz R，Garty BZ，Meshel T，et al. Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in hyper IgE syndrome patients [J]. Immunol Lett，2010，130(1-2)：97-106.
[14] Mogensen TH. STAT3?and the?hyper-IgE syndrome：clinical presentation，genetic origin，pathogenesis，novel findings and remaining uncertainties [J]. JAKSTAT，2013，2(2)：e23435.
[15] Wang L，Arcasoy MO，Watowich SS，et al. Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells [J]. Exp Hematol，2005，33(3)：308-317.
[16] Freeman AF，Holland SM. Clinical manifestations of hyper IgE syndromes [J]. Dis Markers，2010，29(3-4)：123-130.
[17] Schimke LF，Sawalle-Belohradsky J，Roesler J，et al. Diagnostic approach to the hyper-IgE syndromes：immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis [J]. J Allergy Clin Immunol，2010，126(3)：611-617.
[18] Minigishi Y. Hyper-IgE syndrome [J]. Curr Opin Immunol，2009，21(5)：487-492.
[19] Freeman AF，Domingo DL，Holland SM. Hyper IgE (Job's) syndrome：a primary immune deficiency with oral manifestations [J]. Oral Dis，2009，15(1)：2-7.
[20] Zhang Q，Su HC. Hyperimmunoglobulin E syndromes in pediatrics [J]. Curr Opin Pediatr，2011，23(6)：653-658.
[21] Zhang Q，Davis JC，Dove CG，et al. Genetic，clinical，and laboratory markers for DOCK8 immunodeficiency syndrome [J]. Dis Markers，2010，29(3-4)：131-139.
[22] AlKhatib S，Keles S，Garcia-Lloret M，et al. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome [J]. J Allergy Clin Immunol，2009，124(2)：342-348.
[23] Milner JD，Brenchley JM，Laurence A，et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome [J]. Nature，2008，452(7188)：773-776.
[24] Renner ED，Puck JM，Holland SM，et al. Autosomal recessive hyperimmunoglobulin E syndrome：a distinct disease entity [J]. J Pediatr,2004，144(1)：93-99.
[25] Minegishi Y，KarasuyamaH. Hyperimmunoglobulin E syndrome and tyrosine kinase2 deficiency [J]. Curr Opin Allergy Clin Immunol，2007，7(6)：506-509.
[26] Grimbacher B，Holland SM，Gallin J，et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder [J]. N Engl J Med，1999，340(9)：692-702.
[27] O’Connell AC，Puck JM，Grimbacher B，et al. Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod，2000，89(2)：177-185.
[28] Woellner C，Gertz EM，Schaffer A，et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome [J]. J Allergy Clin Immunol，2010，125(2)：424-432.
[29] Freeman AF，Holland SM. Clinical manifestations of hyper IgE syndromes [J]. Dis Markers，2010，29(3-4)：123-130.
[30] Kumar S，Verma S，Khadwal A，et al. Hyper-IgE syndrome：varied infectious presentations in four cases and review of literature [J]. Pediatr Infect Dis J，2013，8(1)：31-37.
[31] 刘琬，常建民. 高IgE综合征 [J]. 中华皮肤科杂志，2007，40(9)，588-589.
[32] Chularojanamontri L，Wimoolchart S，Tuchinda P，et al. Role of oma-lizumab in a patient with hyper-IgE syndrome and review dermatolo-gic manifestations [J]. Asian Pac J Allergy Immunol，2009，27(4)：233-236.
[33] Bard S，Paravisini A，Aviles-Izquierdo JA，et al. Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab [J]. Arch Dermatol，2008，144(12)：1662-1663.
[34] Bittner TC，Pannicke U，Renner ED，et al. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation [J]. Klin Padiatr，2010，222(6)：351-355.
[35] Barlogis V，Galambrun C，Chambost H，et al. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency [J]. J Allergy ClinImmunol，2011，128(2)：420-422.
[36] McDonald DR，Massaad MJ，Johnston A，et al. Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency [J]. J Allergy Clin Immunol，2010，126(6)：1304-1305.
[37] Gatz SA，Benninghoff U，Schutz C，et al. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation [J]. Bone Marrow Transplant，2011，46(4)：552-556.

Hyper-IgE syndrome: recent progress in diagnosis and treatment　Reviewer: LI Chunxiao, Reviser: YU Hong (Department of Dermatology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China)

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Metrics

Comments

Recommended 0

Hyper-IgE syndrome: recent progress in diagnosis and treatment Reviewer: LI Chunxiao, Reviser: YU Hong (Department of Dermatology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China)